Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

WIN 2019 Symposium

23 - 24 Jun 2019
Paris, France
Videos
Efficient in vitro screening for drug combinations: The TEVA model
Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel
Efficient in vitro screening for drug combinations: The TEVA model ( Dr Angel Porgador - Ben-Gurion University of the Negev, Beersheeba, Israel )
10 Jul 2019
The value of personalised medicines for healthcare systems in Europe
Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European...
The value of personalised medicines for healthcare systems in Europe ( Anthony Barron - European Biopharmaceutical Enterprises (EBE) and the European Federation of Pharmaceutical Industries and Associations (EFPIA), Belgium )
10 Jul 2019
Oncobox, RNA sequencing and molecular pathway analysis-base system for...
Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia
Oncobox, RNA sequencing and molecular pathway analysis-base system for prescription of target drugs to advanced cancer patients ( Dr Anton Buzdin - Sechenov Moscow First Medical University, Moscow, Russia )
10 Jul 2019
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in...
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
SPRING 01: Exploring the combination of avelumab, axitinib and palbociclib in patients with advanced metastatic NSCLC ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019
Decision support for precision oncology: Evolving from monotherapy to...
Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA
Decision support for precision oncology: Evolving from monotherapy to genomically informed combinations ( Prof Funda Meric-Bernstam - MD Anderson Cancer Center, Houston, USA )
10 Jul 2019
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast...
Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan
CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer ( Dr Hikmat Abdel-Razeq - King Hussein Cancer Center, Amman, Jordan )
10 Jul 2019
Systems immunology in immuno-oncology
Dr Nikesh Kotecha - Parker Institute for Cancer Immunotherapy, San Francisco...
Systems immunology in immuno-oncology ( Dr Nikesh Kotecha - Parker Institute for Cancer Immunotherapy, San Francisco, USA )
10 Jul 2019
Highlights from WIN 2019
Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman
Highlights from WIN 2019 ( Prof Richard Schilsky - Chief Medical Officer of ASCO and WIN Chairman )
10 Jul 2019
Innovation in clinical trials: WINTHER trial
Prof Razelle Kurzrock - University of California San Diego, San Diego, USA
Innovation in clinical trials: WINTHER trial ( Prof Razelle Kurzrock - University of California San Diego, San Diego, USA )
10 Jul 2019
Data sharing and system interoperability: The Osiris French Program
Dr Pierre Saintigny - Centre Léon Bérard, Lyon, France
Data sharing and system interoperability: The Osiris French Program ( Dr Pierre Saintigny - Centre Léon Bérard, Lyon, France )
10 Jul 2019
RET inhibition in RET aberrant cancers
Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA
RET inhibition in RET aberrant cancers ( Dr Vivek Subbiah - University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019
Goals of the WIN Consortium
Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA
Goals of the WIN Consortium ( Dr Benjamin M. Solomon - Avera Cancer Institute, Sioux Falls, USA )
10 Jul 2019
Lifestyle-based prevention strategies to decrease cancer risk
Dr Jennifer Ligibel - Dana Farber Cancer Institute, Boston, USA
Lifestyle-based prevention strategies to decrease cancer risk ( Dr Jennifer Ligibel - Dana Farber Cancer Institute, Boston, USA )
10 Jul 2019
Rewriting the code of life: CRISPR-Cas9 genome editing
Prof Jennifer Doudna - University of Berkeley, Berkeley, USA
Rewriting the code of life: CRISPR-Cas9 genome editing ( Prof Jennifer Doudna - University of Berkeley, Berkeley, USA )
10 Jul 2019
Gene expression in primary non-small cell lung cancer as a predictor of brain...
Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel
Gene expression in primary non-small cell lung cancer as a predictor of brain metastases ( Dr Jair Bar - Sheba Medical Center, Tel Hashomer, Israel )
10 Jul 2019
A precision medicine approach to therapeutic resistance using KEAP1 somatic...
Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada
A precision medicine approach to therapeutic resistance using KEAP1 somatic mutations ( Dr Gerald Batist - McGill University - Segal Cancer Centre, Montreal, Canada )
10 Jul 2019
Rapidly changing landscape of precision medicine in Japan
Dr Sadakatsu Ikeda - Tokyo Medical and Dental University, Tokyo, Japan
Rapidly changing landscape of precision medicine in Japan ( Dr Sadakatsu Ikeda - Tokyo Medical and Dental University, Tokyo, Japan )
10 Jul 2019
Use of platform studies for the evaluation of innovative combinations in solid...
Dr Elizabeth Pease - AstraZeneca, UK
Use of platform studies for the evaluation of innovative combinations in solid tumours and haematologic malignancies ( Dr Elizabeth Pease - AstraZeneca, UK )
10 Jul 2019
Optimising patient enrolment and efficacy of precision oncology clinical trials
Prof Apostolia-Maria Tsimberidou - The University of Texas MD Anderson Cancer...
Optimising patient enrolment and efficacy of precision oncology clinical trials ( Prof Apostolia-Maria Tsimberidou - The University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019
Integration of DNA and RNA investigations in clinical trials: A laboratory...
Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA
Integration of DNA and RNA investigations in clinical trials: A laboratory challenge ( Brandon Young - Bowden WIN Precision Oncology Laboratory, Murrieta, USA )
10 Jul 2019
Direct targeting of STAT3 alone and in combination with immune checkpoint...
Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston...
Direct targeting of STAT3 alone and in combination with immune checkpoint inhibitors to treat solid tumours ( Dr David Tweardy - The University of Texas MD Anderson Cancer Center, Houston, USA )
10 Jul 2019
Innovative algorithms and IT platform to support clinical trials
Dr Eitan Rubin - Ben-Gurion University of the Negev, Beersheeba, Israel
Innovative algorithms and IT platform to support clinical trials ( Dr Eitan Rubin - Ben-Gurion University of the Negev, Beersheeba, Israel )
10 Jul 2019

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation